Metraipolis › archive › dc_7334bf0f09dd

Characterization and Management of Cytokine Release Syndrome From the MonumenTAL-1 Study of Talquetamab in Patients With Relapsed/Refractory Multiple Myeloma — Europe PMC PMID:41036677

Source: Europe PMC (en)
Original: https://europepmc.org/article/MED/41036677
DOI: 10.1002/cam4.71276
License (as archived): solo-consultazione
Archived: 2026-11-09T15:43:03.702Z
SHA-256 of the archived text: faf00d7d5fb66a8e898cdb4a65fb4e2ce1d838c313feff9997e59cfacb98d9e8
Stable URL of this page: https://metraipolis.com/documento/dc_7334bf0f09dd

How to cite

Characterization and Management of Cytokine Release Syndrome From the MonumenTAL-1 Study of Talquetamab in Patients With Relapsed/Refractory Multiple Myeloma — Europe PMC PMID:41036677 — Europe PMC (en), https://europepmc.org/article/MED/41036677 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_7334bf0f09dd (Metraipolis archive dc_7334bf0f09dd, sha256 faf00d7d5fb66a8e898cdb4a65fb4e2ce1d838c313feff9997e59cfacb98d9e8)

BibTeX

@misc{dc7334bf0f09dd,
  title = {Characterization and Management of Cytokine Release Syndrome From the MonumenTAL-1 Study of Talquetamab in Patients With Relapsed/Refractory Multiple Myeloma — Europe PMC PMID:41036677},
  howpublished = {Europe PMC (en)},
  url = {https://europepmc.org/article/MED/41036677},
  note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_7334bf0f09dd; sha256 faf00d7d5fb66a8e898cdb4a65fb4e2ce1d838c313feff9997e59cfacb98d9e8},
  year = {2026}
}

Archived text

The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/41036677. Agents can read the archived copy with the MCP tool read_document.